Compare
Dentsply Sirona Inc. vs Align Technology Inc vs MiniMed Group, Inc. vs West Pharmaceutical Services Inc
| Latest fiscal year | Dentsply Sirona Inc. XRAY | Align Technology Inc ALGN | MiniMed Group, Inc. MMED | West Pharmaceutical Services Inc WST |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-04-24 | 2025-12-31 |
| Revenue | $3.68B | $4.03B | $3.10B | $3.07B |
| Revenue growth (YoY) | -3.0% | +0.9% | +14.3% | +6.3% |
| Gross margin | 50.0% | 67.2% | 54.2% | 35.9% |
| Operating margin | -11.5% | 13.5% | -6.1% | 19.0% |
| Net margin | -16.3% | 10.2% | -10.7% | 16.1% |
| Net income | -$598.00M | $410.35M | -$333.00M | $493.70M |
| EPS (Diluted) | -$3.00 | $5.65 | -$1.30 | $6.79 |
| Operating cash flow | $235.00M | $593.22M | -$197.00M | $754.80M |
| Free cash flow | $104.00M | $490.78M | -$420.00M | $468.90M |
| Cash & equivalents | $326.00M | $1.09B | $298.00M | $791.30M |
| Total assets | $5.43B | $6.23B | $4.63B | $4.27B |
| Total liabilities | $4.09B | $2.18B | $1.02B | $1.09B |
| Shareholders' equity | $1.34B | $4.05B | $3.61B | $3.18B |
| Return on year-end equity | -44.6% | 10.1% | -9.2% | 15.5% |
| Shares outstanding | 199.60M | 71.36M | 280.82M | 72.00M |
Revenue, most recent five fiscal years
| Fiscal year | Dentsply Sirona Inc. | Align Technology Inc | MiniMed Group, Inc. | West Pharmaceutical Services Inc |
|---|---|---|---|---|
| Latest | $3.68B Ended 2025-12-31 | $4.03B Ended 2025-12-31 | $3.10B Ended 2026-04-24 | $3.07B Ended 2025-12-31 |
| 1 year earlier | $3.79B Ended 2024-12-31 | $4.00B Ended 2024-12-31 | $2.71B Ended 2025-04-25 | $2.89B Ended 2024-12-31 |
| 2 years earlier | $3.96B Ended 2023-12-31 | $3.86B Ended 2023-12-31 | $2.47B Ended 2024-04-26 | $2.95B Ended 2023-12-31 |
| 3 years earlier | $3.92B Ended 2022-12-31 | $3.73B Ended 2022-12-31 | n/a | $2.89B Ended 2022-12-31 |
| 4 years earlier | $4.23B Ended 2021-12-31 | $3.95B Ended 2021-12-31 | n/a | $2.83B Ended 2021-12-31 |